Health Canada news from FierceBiotech
NewsCanada's streamlined approval process raises protests
Canadian officials are batting down critics who say that the country's new, streamlined drug approval process will let unsafe therapies onto the market. The dispute centers on Canada's new standard Read more...
Canadian regulators forging new biosimilar pathway
While U.S. lawmakers jawbone about a regulatory pathway for biosimilars, or biogenerics, Read more...
| Press ReleasesPRESS RELEASE: Health Canada/Information Update: New Safety Information Regarding Prexige (Lumiracoxib)Health Canada/Information Update: New Safety Information Regarding Prexige (Lumiracoxib) OTTAWA, Aug. 16 -- Health Canada is currently requesting and reviewing new safety information regarding Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends